T80.410D Rh incompatibility with acute hemolytic transfusion reaction, subsequent encounter

Name of the Condition

• Rh incompatibility with acute hemolytic transfusion reaction, subsequent encounter.

Summary

This condition describes an immune-mediated hemolytic reaction occurring during a subsequent encounter after an initial transfusion, where Rh-negative individuals have received Rh-positive blood or blood products. It results from the recipient’s immune system recognizing Rh antigens as foreign, triggering antibody production and subsequent hemolysis. The "subsequent encounter" designation indicates ongoing care related to the reaction.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources. The subsequent encounter implies prior exposure and ongoing management of the reaction.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history. Laboratory tests such as direct antiglobulin testing (Coombs test) may be used to detect hemolysis. Documentation of the transfusion and subsequent clinical course is essential.

Treatment Options

Treatment focuses on managing hemolysis and preventing further complications. This may include discontinuing the transfusion, administering intravenous fluids, and using medications to support kidney function or reduce immune response. Close monitoring of vital signs and laboratory values is critical.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most patients recover with appropriate treatment, but severe cases may lead to organ damage. Follow-up care involves monitoring for delayed reactions and ensuring Rh compatibility in future transfusions.

Complications

• Acute kidney injury due to hemoglobinuria
• Disseminated intravascular coagulation (DIC)
• Shock or hypotension
• Severe anemia requiring additional transfusions

Lifestyle & Prevention

Prevention includes thorough blood typing and crossmatching before transfusions. Rh-negative individuals should receive Rh-compatible blood products whenever possible. In cases of prior sensitization, prophylactic measures may be considered to reduce future reaction risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, jaundice, or shortness of breath occur after a transfusion. Prompt evaluation is necessary to prevent severe complications.

Tips for Medical Coders

Document the transfusion history, clinical symptoms, and laboratory findings to support the diagnosis. Ensure the "subsequent encounter" designation is used only for ongoing care related to the reaction. Code T80.410D is specific to acute hemolytic transfusion reactions with Rh incompatibility during a subsequent encounter.